Geldanamycin derivative and method of treating cancer using same

Details for Australian Patent Application No. 2002307020 (hide)

Owner The Government of The United States of America, as Represented by The Secretary, Department of Health and Human Services

Inventors Sausville, Edward A; Snader, Kenneth M; Hollingshead, Melinda G; Vishnuvajjala, B Rao

Agent Pizzeys

Pub. Number AU-B-2002307020

PCT Number PCT/US02/10097

PCT Pub. Number WO2002/079167

Priority 60/280,078 30.03.01 US

Filing date 28 March 2002

Wipo publication date 15 October 2002

Acceptance publication date 28 June 2007

International Classifications

C07D 225/06 (2006.01) Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/280,078 30.03.01 US

3 April 2003 Application Open to Public Inspection

  Published as AU-B-2002307020

28 June 2007 Application Accepted

  Published as AU-B-2002307020

25 October 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002307021-CONTENT SECURITY LAYER PROVIDING LONG-TERM RENEWABLE SECURITY

2002307019-METHOD OF ESTIMATING MEASURING ACCURACY OF DISPENSING METERS